Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer

Clinical trial NCT02676986 · COMPLETED

Trial details

NCT number: NCT02676986
Sponsor: Queen Mary University of London
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Breast Cancer ER+ve Primary Breast Cancer AR+ve TNBN

Start date: 2015-08-10
Primary completion: 2016-12-31
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.